@article{0f0257c879294f5e84db40f523df1f3b,
title = "Atrial fibrillation, with ACS and PCI: Walking a tightrope",
author = "Roxana Mehran and Kalkman, {Deborah N.} and Angiolillo, {Dominick J.}",
note = "Funding Information: honorarium from Amgen, Aralez, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, PLx Pharma, Pfizer, Sanofi, and The Medicines Company; and participation in review activities from CeloNova and St. Jude Medical; and has also received institutional payments for grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli-Lilly, Gilead, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, Osprey Medical, and Renal Guard Solutions. D.N.K reports no relationships relevant to the contents of this paper to disclose.",
year = "2019",
month = may,
day = "1",
doi = "10.1093/eurheartj/ehz192",
language = "English",
volume = "40",
pages = "1563--1566",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "19",
}